Agios Pharmaceuticals price target raised to $50 from $46
Benzinga reports B of A Securities raised its Agios Pharmaceuticals price target to $50.00 per share from $46.00.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Benzinga reports B of A Securities raised its Agios Pharmaceuticals price target to $50.00 per share from $46.00.